+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Generalized Anxiety Disorder Market by Treatment Type (Digital Therapeutics, OTC Supplements, Prescription Drugs), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Patient Age Group, Gender, Symptom Severity - Global Forecast 2025-2030- Product Image
Generalized Anxiety Disorder Market by Treatment Type (Digital Therapeutics, OTC Supplements, Prescription Drugs), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Patient Age Group, Gender, Symptom Severity - Global Forecast 2025-2030- Product Image
Sale

Generalized Anxiety Disorder Market by Treatment Type (Digital Therapeutics, OTC Supplements, Prescription Drugs), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), Patient Age Group, Gender, Symptom Severity - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016467
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Leaders navigating the evolving generalized anxiety disorder (GAD) market face a healthcare environment undergoing rapid transformation. This report offers strategic clarity for stakeholders as new therapies, digital health models, and supply chain dynamics reshape anxiety care at a global level.

Market Snapshot: Generalized Anxiety Disorder Market Size and Growth

The Generalized Anxiety Disorder Market grew from USD 2.23 billion in 2024 to USD 2.36 billion in 2025. Projected to expand at a CAGR of 5.56%, the market is expected to reach USD 3.09 billion by 2030. Growth is driven by advances in digital health, pharmacological innovation, and expanding access to patient-centered care worldwide.

Scope & Segmentation of the Generalized Anxiety Disorder Market

  • Treatment Types: Digital therapeutics (including mobile cognitive behavioral therapy apps, mindfulness platforms, online solutions, and virtual reality); OTC supplements; Prescription drugs (benzodiazepines, buspirone, SNRIs, SSRIs); Therapy services (individual CBT, group therapy, psychodynamic therapy, supportive counseling)
  • Distribution Channels: Hospital pharmacies; Online pharmacies (e-commerce portals, telepharmacy services); Retail pharmacies
  • Patient Age Groups: Adolescents; Adults; Children; Elderly
  • Gender: Female; Male
  • Symptom Severity: Mild; Moderate; Severe
  • Geographic Regions: Americas (United States - California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Pfizer Inc.; Eli Lilly and Company; GlaxoSmithKline plc; AbbVie Inc.; H. Lundbeck A/S; Roche Holding AG; Teva Pharmaceuticals Industries Ltd.; Viatris Inc.; Sandoz International GmbH; Dr. Reddy’s Laboratories Ltd.

Key Takeaways for Senior Decision-Makers

  • The treatment landscape is shifting as digital therapeutics become integral for both standalone and adjunct anxiety management across multiple settings.
  • Telehealth and virtual platforms are enabling broader remote delivery of therapies, creating scalable options for cognitive behavioral interventions and supportive care programs.
  • Precision medicine is gaining traction, with the adoption of genetic profiling and biomarkers guiding pharmacological treatment selection for enhanced clinical outcomes.
  • Collaborative care models are expanding, integrating continuous digital monitoring, patient education, and real-time feedback to improve engagement and adherence.
  • Segmentation by demographics and symptom severity lets providers and manufacturers adapt offerings to address age-specific needs and symptom variations for targeted, effective solutions.
  • Regional differences in reimbursement, regulatory oversight, and local innovation foster both opportunities and challenges, requiring region-specific strategies for access and collaboration.

Tariff Impact on Treatment Access and Supply Chain Innovation

Revised United States tariffs implemented in 2025 affected sourcing of pharmaceutical ingredients and digital hardware. Manufacturers and distributors have been prompted to reconsider procurement and develop domestic manufacturing partnerships. The sector is increasingly resilient due to a shift toward local production and alternative treatment modalities, although some short-term challenges in costs and delivery persist.

Methodology & Data Sources

This analysis applies a mixed-methods approach, combining primary stakeholder interviews with secondary research from peer-reviewed literature, regulatory documents, and health databases. Validation includes qualitative thematic analysis and quantitative benchmarking, with scenario planning to address potential regulatory and market shifts.

Why This Report Matters for Generalized Anxiety Disorder Market Strategy

  • Enables strategic planning by highlighting global market and technology shifts, allowing for evidence-based decisions on investment and expansion.
  • Facilitates risk and opportunity assessment in light of changing supply chain, regulatory, and reimbursement trends relevant to GAD care.
  • Supports cross-functional collaboration with actionable segmentation insights and an understanding of region-specific dynamics and partnership opportunities.

Conclusion

This report delivers insight into the changing patterns shaping generalized anxiety disorder treatment. Stakeholders now have a clear foundation to guide investment, innovation, and collaboration in a progressively digital, data-driven care landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of digital therapeutics platforms for personalized anxiety management
5.2. Expansion of telepsychiatry services driven by relaxed reimbursement and licensure regulations
5.3. Integration of AI-driven chatbots and virtual coaches in continuous anxiety symptom monitoring
5.4. Surge in demand for plant-based and cannabidiol formulations for generalized anxiety disorder relief
5.5. Emergence of precision psychiatry using genetic and biomarker profiling for targeted anxiety treatment
5.6. Growth of corporate mental wellness programs emphasizing proactive anxiety prevention strategies
5.7. Development of virtual reality exposure therapies for immersive anxiety management interventions
5.8. Increased utilization of wearable biosensors and digital biomarkers in anxiety condition tracking
5.9. Rise of no-code mental health app development empowering nontechnical anxiety coaches and patients
5.10. Adoption of guided microdosing protocols with psychedelics for treatment-resistant anxiety cases
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Generalized Anxiety Disorder Market, by Treatment Type
8.1. Introduction
8.2. Digital Therapeutics
8.2.1. Mobile Apps
8.2.1.1. Cognitive Behavioral Therapy Apps
8.2.1.2. Mindfulness Apps
8.2.2. Online Platforms
8.2.3. Virtual Reality
8.3. OTC Supplements
8.4. Prescription Drugs
8.4.1. Benzodiazepines
8.4.2. Buspirone
8.4.3. SNRIs
8.4.4. SSRIs
8.5. Therapy Services
8.5.1. Cognitive Behavioral Therapy
8.5.2. Group Therapy
8.5.3. Psychodynamic Therapy
8.5.4. Supportive Counseling
9. Generalized Anxiety Disorder Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.3.1. E-Commerce Portals
9.3.2. Telepharmacy Services
9.4. Retail Pharmacies
10. Generalized Anxiety Disorder Market, by Patient Age Group
10.1. Introduction
10.2. Adolescents
10.3. Adults
10.4. Children
10.5. Elderly
11. Generalized Anxiety Disorder Market, by Gender
11.1. Introduction
11.2. Female
11.3. Male
12. Generalized Anxiety Disorder Market, by Symptom Severity
12.1. Introduction
12.2. Mild
12.3. Moderate
12.4. Severe
13. Americas Generalized Anxiety Disorder Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Generalized Anxiety Disorder Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Generalized Anxiety Disorder Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Eli Lilly and Company
16.3.3. GlaxoSmithKline plc
16.3.4. AbbVie Inc.
16.3.5. H. Lundbeck A/S
16.3.6. Roche Holding AG
16.3.7. Teva Pharmaceuticals Industries Ltd.
16.3.8. Viatris Inc.
16.3.9. Sandoz International GmbH
16.3.10. Dr. Reddy’s Laboratories Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GENERALIZED ANXIETY DISORDER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GENERALIZED ANXIETY DISORDER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GENERALIZED ANXIETY DISORDER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GENERALIZED ANXIETY DISORDER MARKET: RESEARCHAI
FIGURE 26. GENERALIZED ANXIETY DISORDER MARKET: RESEARCHSTATISTICS
FIGURE 27. GENERALIZED ANXIETY DISORDER MARKET: RESEARCHCONTACTS
FIGURE 28. GENERALIZED ANXIETY DISORDER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENERALIZED ANXIETY DISORDER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY APPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY APPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MINDFULNESS APPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MINDFULNESS APPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY VIRTUAL REALITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY VIRTUAL REALITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY OTC SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY OTC SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY BUSPIRONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY BUSPIRONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SNRIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SNRIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SSRIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SSRIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GROUP THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GROUP THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PSYCHODYNAMIC THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PSYCHODYNAMIC THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SUPPORTIVE COUNSELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SUPPORTIVE COUNSELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY E-COMMERCE PORTALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY E-COMMERCE PORTALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TELEPHARMACY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TELEPHARMACY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ADOLESCENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY CHILDREN, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY FEMALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MODERATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MODERATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SEVERE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SEVERE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 135. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 138. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 139. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 140. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 141. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 142. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 143. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 144. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 145. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 148. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 149. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 150. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 151. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 152. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 153. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 154. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 164. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 165. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 168. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 169. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 170. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 171. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 257. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 258. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 259. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 262. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 263. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 264. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 265. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 266. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 267. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 270. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 271. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 272. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 273. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 274. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 275. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 276. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 277. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 278. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 279. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 282. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 283. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2024 (USD MILLION)
TABLE 284. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2025-2030 (USD MILLION)
TABLE 285. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2024 (USD MILLION)
TABLE 286. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2025-2030 (USD MILLION)
TABLE 287. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 290. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 291. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 292. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 293. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
TABLE 294. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2025-2030 (USD MILLION)
TABLE 295. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2024 (USD MILLION)
TABLE 296. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA GENERALIZED

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Generalized Anxiety Disorder market report include:
  • Pfizer Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • H. Lundbeck A/S
  • Roche Holding AG
  • Teva Pharmaceuticals Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Dr. Reddy’s Laboratories Ltd.

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.36 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.09 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Generalized Anxiety Disorder Market Report and Forecast 2025-2034 - Product Image

Generalized Anxiety Disorder Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Generalized Anxiety Disorder - Pipeline Insight, 2025 - Product Image

Generalized Anxiety Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Generalized Anxiety Disorder Market Report 2025 - Product Image

Generalized Anxiety Disorder Market Report 2025

  • Report
  • 200 Pages
  • Global
From
General Anxiety Disorder (GAD) - Pipeline Insight, 2025 - Product Image

General Anxiety Disorder (GAD) - Pipeline Insight, 2025

  • Clinical Trials
  • 40 Pages
  • Global
From
Anxiety Disorder Treatment - Global Strategic Business Report - Product Image

Anxiety Disorder Treatment - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From

About the Generalized Anxiety Disorder Market

Generalized Anxiety Disorder (GAD) is a prevalent mental health condition characterized by chronic and excessive worry about multiple events or activities, often disproportionate to the actual likelihood or impact of the perceived threats. The GAD market encompasses a range of treatments and services aimed at managing symptoms and improving quality of life for individuals diagnosed with this disorder. Therapeutic approaches include pharmacotherapy, with medications such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) being commonly prescribed. Psychotherapy, particularly cognitive-behavioral therapy (CBT), is also a core component of treatment, offering strategies to modify anxious thought patterns and reduce avoidance behaviors. Additionally, the market includes supportive services such as self-help groups and online resources aimed at educating patients and carers about the disorder. Several pharmaceutical and healthcare companies are active in the GAD market, providing medications, therapies, and services to patients. Some notable players in this market include Pfizer, with products like sertraline (Zoloft), and Eli Lilly, which manufactures duloxetine (Cymbalta). Moreover, GlaxoSmithKline's paroxetine (Paxil) is another therapeutic option for GAD. On the psychotherapeutic front, companies like Talkspace and BetterHelp offer online counseling services, expanding access to mental health care. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.